Highlights From The ESMO Gastrointestinal Cancers Congress 2025 by Cathy Eng
The ESMO Gastrointestinal Cancers Congress 2025 is taking place from July 2-5 in Barcelona, Spain, with an online option available through a dedicated virtual platform. Organized by the European Society for Medical Oncology, this key event gathers leading experts, researchers, and healthcare professionals who are focused on advancing treatment and care for gastrointestinal cancers.
Attendees are experiencing groundbreaking presentations, multidisciplinary tumor boards, and lively discussions on the latest research, innovative therapies, and emerging technologies. The program covers a wide range of topics, including molecular prevention, precision therapy, and patient-centered approaches. In addition, there are plenty of networking opportunities for participants to connect with peers and share ideas.
Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared Highlights From ESMO GI 2025 on X:
“Small ESMOGI25 reunion in the faculty room! Great way to start the AM. Some of my fave people: Dr. Eileen O’Reilly, Angela Lamarca and Karyn A Goodman
Missed our photo opportunity with Rachel Riechelmann!”
“Day 2 and bumped into the lovely Erika Ruiz-Garcia before our AM sessions: Multi-D Rectal cancer (Madrid room) and NGS on pancreatic cancer (BCN room).”
“Thanks to all that showed up for our multi-D rectal cancer session at ESMO. GREAT discussion with Drs. Prager, Garcia-Aguilar and Vendrely.”
“Excellent Keynote Speaker F. Di Nicolantonio genomic and transcriptome colorectal cancer signatures.”
“The evolving role for AI in GI cancer.”
“Wonderful faculty dinner last night! Karyn A Goodman, Erika Ruiz-Garcia, Irit Ben-Aharon, Rachel Riechelmann, Lizzy Smyth, Teresa Macarulla, Juan OConnor and so many others!”
“Dr. Julian Taieb is giving an excellent overview of ctDNA and prognosis and its challenges in the Valencia room now..”
“Fantastic lecture on creation of the definition of oligometastatic disease for esophageal cancer Dr. Hannake van Laarhoven.”
“Really enjoyed our session with the ESMO G.I. Editors: Irit Ben-Aharon, Florian Lordick and Drs. Westphalen, Taieb, and van Laarhoven.
We encourage you to SUBMIT your Cancer Research manuscripts.”
“Day 3 ESMO but need to acknowledge my fantastic colleagues at Bristol Myers Squibb, Tanios Bekaii-Saab, Dr. Shubham Pant, Midhun Malla, Patrick Boland
One mission treatment advances for G.I. cancer patients.”
“Interesting and promising data re: vaccine therapy in pancreatic cancer from Vinod Balachandran.”
“Great talk from Dr. M Overman, MD Anderson Cancer Center re: overview on the role of immunotherapy in colorectal cancer. Looking forward to this paper in press from Van Morris re: correlates from his phase 2 single arm study for BRAF refractory CRC patients with IO.”
“Happening now: Dr. Rene Adam providing an update on metastatic colorectal cancer to the liver regarding Transmet study and liver transplant.”
““NEVER give up” is the message! From the renowned Dr. Rene Adam.”
“Happening now: Chiara Cremolini discussing sidedness of colorectal cancer.”
“Happening now: Dr. Takayuki Yoshino is presenting his approach to personalized oncology for met CRC.”
“Closing the session is Michael Overman re: where are with re: immunotherapy in met colorectal cancer. Excellent lecture re: future developments!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023